Form 6-K RedHill Biopharma Ltd. For: Feb 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
RedHill Biopharma (RDHL) Tops Q4 EPS Views
February 26, 2015 7:54 AM ESTRedHill Biopharma (NASDAQ: RDHL) reported Q4 EPS of $0.06, $0.66 better than the analyst estimate of ($0.60).
EPS in Q413 was 0.05.
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
... More


